Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study

Background: Hyperuricemia is an established risk factor for cardiovascular disease, including atrial fibrillation (AF). The prevalence of hyperuricemia and its clinical significance in patients with already diagnosed AF remain unexplored. Methods: The Polish Atrial Fibrillation (POL-AF) registry inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wełnicki, Marcin, Gorczyca, Iwona, Wójcik, Wiktor, Jelonek, Olga, Maciorowska, Małgorzata, Uziębło-Życzkowska, Beata, Wójcik, Maciej, Błaszczyk, Robert, Rajtar-Salwa, Renata, Tokarek, Tomasz, Bil, Jacek, Wojewódzki, Michał, Szpotowicz, Anna, Krzciuk, Małgorzata, Gawałko, Monika, Kapłon-Cieślicka, Agnieszka, Tomaszuk-Kazberuk, Anna, Szyszkowska, Anna, Bednarski, Janusz, Bakuła-Ostalska, Elwira, Wożakowska-Kapłon, Beata, Mamcarz, Artur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122779/
https://www.ncbi.nlm.nih.gov/pubmed/33922386
http://dx.doi.org/10.3390/jcm10091829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122779/
https://www.ncbi.nlm.nih.gov/pubmed/33922386
http://dx.doi.org/10.3390/jcm10091829

Ejemplares similares